Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.16USD
23 Feb 2018
Change (% chg)

$-0.04 (-3.33%)
Prev Close
$1.20
Open
$1.20
Day's High
$1.23
Day's Low
$1.14
Volume
64,735
Avg. Vol
95,563
52-wk High
$1.92
52-wk Low
$0.79

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Regulus Therapeutics Files For Mixed Shelf Of Up To $150 Mln

* REGULUS THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text: (http://bit.ly/2rQDgcO) Further company coverage:

29 Jan 2018

BRIEF-Regulus Therapeutics Q3 loss per share $0.18

* Regulus reports third quarter 2017 financial results and recent events

08 Nov 2017

BRIEF-Regulus Q3 loss per share $0.18

* Regulus reports third quarter 2017 financial results and recent events

07 Nov 2017

Competitors

Earnings vs. Estimates